As of January 1, 2024, the asthma inhalers Flovent HFA and Flovent Diskus have been discontinued. These medications, widely used for asthma management, are no longer available.
Key Information Regarding the Discontinuation
The decision to discontinue these specific asthma treatments was made by their manufacturer, GSK, who announced the change last year.
- Inhalers Affected: The specific inhaler products that are no longer available are:
- Flovent HFA (fluticasone propionate HFA inhalation aerosol)
- Flovent Diskus (fluticasone propionate inhalation powder)
- Effective Date: These medications ceased to be available as of January 1, 2024.
- Manufacturer's Decision: GSK, the pharmaceutical company responsible for Flovent, announced its discontinuation of these asthma medications.
Impact on Patients
The discontinuation of Flovent HFA and Flovent Diskus has significant implications for individuals who have relied on these inhalers for their asthma control. Patients who were prescribed these medications will need to transition to alternative treatments. It is crucial for anyone affected to consult their healthcare provider promptly to discuss new medication plans. This will ensure continuous and effective asthma management, preventing any potential gaps in treatment.
